VHL-P138R and VHL-L163R Novel Variants: Mechanisms of VHL Pathogenicity Involving HIF-Dependent and HIF-Independent Actions
The von Hippel–Lindau (VHL) disease is an autosomal dominant cancer syndrome caused by mutations in the VHL tumor suppressor gene. VHL protein (pVHL) forms a complex (VBC) with Elongins B-C, Cullin2, and Rbx1. Although other functions have been discovered, the most described function of pVHL is to r...
Main Authors: | Cecilia Mathó, María Celia Fernández, Jenner Bonanata, Xian-De Liu, Ayelen Martin, Ana Vieites, Gabriela Sansó, Marta Barontini, Eric Jonasch, E. Laura Coitiño, Patricia Alejandra Pennisi |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.854365/full |
Similar Items
-
Identification of 3 novel <it>VHL</it> germ-line mutations in Danish VHL patients
by: Dandanell Mette, et al.
Published: (2012-07-01) -
Variants in the new E1ʹ cryptic exon of the VHL gene associated with congenital erythrocytosis—Description of three cases
by: Catarina Dantas Rodrigues, et al.
Published: (2022-08-01) -
Corrigendum: VHL-Mediated Regulation of CHCHD4 and Mitochondrial Function
by: Thomas Briston, et al.
Published: (2021-09-01) -
Identification of a VHL gene mutation in atypical Von Hippel-Lindau syndrome: genotype–phenotype correlation and gene therapy perspective
by: Dali Tong, et al.
Published: (2021-12-01) -
Von Hippel–Lindau (VHL) disease and VHL-associated tumors in Indian subjects: VHL gene testing in a resource constraint setting
by: Aradhana Dwivedi, et al.
Published: (2022-08-01)